Dear Colleagues,
Dear Friends,

The second ESMINT Congress will be held in Nice, from September 9 to 11, 2010!

I remind you that the goal of the ESMINT Congress is to gather neuroradiologists neurosurgeons and neurologists and discuss indications, strategies, new techniques and news devices, difficult cases and morbi-mortality as well as research and protocols concerning endovascular treatment of neurovascular diseases.

Like last year we will have:

• Controversies by two invited speakers of opposite opinions
• How I do it sessions
• Many Cases discussions on morbi-mortality
• The best success of the year! A lesson or technique to learn!
• The worse complication of the year! The big mistakes to avoid!
• A review of the main ongoing or achieved series!
• A scientific lecture on cerebral perfusion imaging

Just as a draft I propose the following controversies:

• How often should we use the remodelling technique, always, almost always or only in specific indications?
• Flow dynamic modelization: is it useful for clinical practice?
• Should we use stents in ruptured aneurysms?
• Flow diverters or homemade Flow diverters with multiple stents?
• Benign Intracranial Hypertension: Should we Stent or not?

A session will be dedicated to Flow diverters and panelists will have to answer the following questions:

• Risk of rupture of unruptured aneurysms after FD: Should we coil before using a FD?
• Risk of perforators occlusion?
• Should we use FD in bifurcations?
• Risk of acute and delayed aneurysm thrombosis and complications?
• How much should we divert the flow (on which evidence)?

A review of the main ongoing or achieved series!

• TEAM is dead, is ARUBA still alive?
• Bioactive coils: something new? Any reason to use them?
• Should we trust the results of Helps? Should we use only Hydrocoils?
• Carotid stenting: When do complications occur, before during or after stenting? A meta-analysis of the 3 European Studies!
• Presentation of results on FD ongoing or achieved studies

Guidelines for patient selection for IA acute stroke treatment: In absence of any Evidence Based Medicine, how to select candidates for IA recanalization?

Cases discussions on morbi-mortality: Aneurysms, AVM, AVF, Stroke, IC stenting, cerebral venous thrombosis, miscellaneous...

Usual communications concerning case series or clinical trials will not be accepted!

On the contrary we would like participants to show interesting or challenging cases. To present complications, discuss strategy, indication and technique. Participants will be asked to send just the title of the case presentation and power point file.

This congress must be as much interactive as possible!

I hope this meeting will stimulate discussions, debates and controversies that will open our minds, enlarge our knowledge and eventually influence our practice.

Pr. Christophe Cognard